Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORLATINIB Cause Wrong technique in product usage process? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Wrong technique in product usage process have been filed in association with LORLATINIB (Lorbrena). This represents 0.5% of all adverse event reports for LORLATINIB.

29
Reports of Wrong technique in product usage process with LORLATINIB
0.5%
of all LORLATINIB reports
8
Deaths
2
Hospitalizations

How Dangerous Is Wrong technique in product usage process From LORLATINIB?

Of the 29 reports, 8 (27.6%) resulted in death, 2 (6.9%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does LORLATINIB Cause?

Death (1,050) Neoplasm progression (633) Off label use (394) Weight increased (306) Hallucination (290) Blood cholesterol increased (281) Dyspnoea (223) Oedema peripheral (198) Oedema (195) Fatigue (188)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which LORLATINIB Alternatives Have Lower Wrong technique in product usage process Risk?

LORLATINIB vs LORMETAZEPAM LORLATINIB vs LORNOXICAM LORLATINIB vs LOSARTAN LORLATINIB vs LOSARTAN\LOSARTAN LORLATINIB vs LOTEPREDNOL ETABONATE

Related Pages

LORLATINIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process LORLATINIB Demographics